Literature DB >> 29602739

Negative symptoms of schizophrenia: new developments and unanswered research questions.

Silvana Galderisi1, Armida Mucci2, Robert W Buchanan3, Celso Arango4.   

Abstract

Negative symptoms of schizophrenia are associated with poor functional outcome and place a substantial burden on people with this disorder, their families, and health-care systems. We summarise the evolution of the conceptualisation of negative symptoms, the most important findings, and the remaining open questions. Several studies have shown that negative symptoms might be primary to schizophrenia or secondary to other factors, and that they cluster in the domains of avolition-apathy and expressive deficit. Failure to take this heterogeneity into account might hinder progress in research on neurobiological substrates and discoveries of treatments for primary or enduring negative symptoms. Improvement in recognition and routine assessment of negative symptoms is instrumental for correct management of secondary negative symptoms that are amenable to treatment. If substantial progress is to be made in the understanding and treatment of negative symptoms, then advances in concepts and assessment should be integrated into the design of future studies of these symptoms.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29602739     DOI: 10.1016/S2215-0366(18)30050-6

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  62 in total

1.  New-Onset Psychosis Associated With a Lesion Localized in the Rostral Tectum: Insights Into Pathway-Specific Connectivity Disrupted in Psychosis.

Authors:  Eleftheria Koropouli; Nikos Melanitis; Vasileios I Dimitriou; Asimina Grigoriou; Efstratios Karavasilis; Konstantina S Nikita; Elias Tzavellas; Thomas Paparrigopoulos
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

2.  How Early Life Adversities Influence Later Life Family Interactions for Individuals with Schizophrenia in Outpatient Treatment: A Qualitative Analysis.

Authors:  Supriya Misra; Kelsey A Johnson; Lindsey M Parnarouskis; Karestan C Koenen; David R Williams; Bizu Gelaye; Christina P C Borba
Journal:  Community Ment Health J       Date:  2020-05-09

3.  The clinical characterization of the patient with primary psychosis aimed at personalization of management.

Authors:  Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura
Journal:  World Psychiatry       Date:  2021-02       Impact factor: 49.548

4.  Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.

Authors:  Cynthia Z Burton; Ivy F Tso; Ricardo E Carrión; Tara Niendam; Steven Adelsheim; Andrea M Auther; Barbara A Cornblatt; Cameron S Carter; Ryan Melton; Tamara G Sale; Stephan F Taylor; William R McFarlane
Journal:  Schizophr Res       Date:  2019-08-06       Impact factor: 4.939

Review 5.  Gesture deficits and apraxia in schizophrenia.

Authors:  Sebastian Walther; Vijay A Mittal; Katharina Stegmayer; Stephan Bohlhalter
Journal:  Cortex       Date:  2020-10-03       Impact factor: 4.027

6.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

7.  A comprehensive model of predictors of quality of life in older adults with schizophrenia: results from the CSA study.

Authors:  Nicolas Hoertel; Léa Rotenberg; Carlos Blanco; Vincent Camus; Caroline Dubertret; Véronique Charlot; Franck Schürhoff; Pierre Vandel; Frédéric Limosin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-05-15       Impact factor: 4.328

8.  Heterogeneity of emotional experience in schizophrenia: Trait affect profiles predict clinical presentation and functional outcome.

Authors:  Henry R Cowan; Vijay A Mittal; Daniel N Allen; James M Gold; Gregory P Strauss
Journal:  J Abnorm Psychol       Date:  2020-06-25

9.  Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.

Authors:  D J Devoe; L Lu; T D Cannon; K S Cadenhead; B A Cornblatt; T H McGlashan; D O Perkins; L J Seidman; M T Tsuang; S W Woods; E F Walker; D H Mathalon; C E Bearden; J Addington
Journal:  Schizophr Res       Date:  2020-04-30       Impact factor: 4.939

Review 10.  Targeting muscarinic receptors to treat schizophrenia.

Authors:  Daniel J Foster; Zoey K Bryant; P Jeffrey Conn
Journal:  Behav Brain Res       Date:  2021-02-26       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.